# As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR

> **NCT04459572** · NA · COMPLETED · sponsor: **Ege University** · enrollment: 72 (actual)

## Conditions studied

- Septic Shock
- Sepsis, Severe

## Interventions

- **DIAGNOSTIC_TEST:** suPAR

## Key facts

- **NCT ID:** NCT04459572
- **Lead sponsor:** Ege University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-27
- **Primary completion:** 2019-09-27
- **Final completion:** 2020-06-25
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04459572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04459572, "As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04459572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*